Halozyme Therapeutics | Pasivo Circulante



Current Liabilities Cambio Fecha
Acadia Pharmaceuticals USD 302.53M 92.34M 2025-03
Agios Pharmaceuticals USD 52.37M 28.79M 2025-03
Alnylam Pharmaceuticals USD 1.08B 110.65M 2025-03
Amarin USD 201.55M 28.99M 2024-09
Amgen USD 23.01B 91M 2025-03
Baxter International USD 6.51B 311M 2024-12
Cytokinetics USD 159.73M 19.95M 2025-03
DBV Technologies USD 30.91M 3.53M 2024-09
Eli Lilly USD 30.07B 1.69B 2025-03
Halozyme Therapeutics USD 150.38M 11.28M 2025-03
Indivior 1.01B 66M 2025-03
Ionis Pharmaceuticals USD 250.29M 59.02M 2025-03
MannKind USD 115.94M 34.1M 2025-03
Pfizer USD 36.45B 6.54B 2025-03
United Therapeutics USD 721.5M 16.6M 2025-03



Halozyme Therapeutics Pasivo Circulante - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - May 2025.